abs380.txt	purpose		effective	treatment	of	patients	with	locally	advanced	pancreatic	canceris	a	significant	unmet	clinical	need	one	major	hurdle	that	exists	is	inadequatedrug	delivery	due	to	the	desmoplastic	stroma	and	poor	vascularization	ischaracteristic	cancer	local	iontophoretic	ofchemotherapies	provides	novel	way	improving	growingpractice	highly	toxic	combination	therapies	in	pancreaticcancer	use	iontophoresis	for	can	potentiate	theanti-cancer	effects	these	while	sparing	unwanted	toxicity	theobjective	this	study	was	investigate	impact	formulation	on	theelectro-transport	folfirinox	regimen	development	newtreatment	methods	three	formulations	(5-fluorouracil	leucovorin	irinotecan	oxaliplatin)	were	generated	at	fixed	ph	6	0	andwere	referred	as	(single	drug	solution	all	four	drugscombined)	b	(two	solutions	two	drugs	per	solution)	andformulation	c	(four	individual	solutions)	anodic	threedifferent	evaluated	orthotopic	patient-derived	xenografts	ofpancreatic	results	transport	characterizedaccording	organ	exposure	after	single	device	vivo	we	reportthat	co-iontophoresis	+	oxaliplatin	and5-fluorouracil	resulted	highest	levels	cytotoxic	inthe	tumor	compared	delivered	individually	or	combined	into	there	no	difference	plasma	pancreas	kidney	liverexposure	by	different	inaddition	found	reducing	duration	from	10to	5	min	decrease	concentrations	conclusions	underlying	waselectrolyte	which	includes	both	active	inactive	components	electrolyte	hinder	improve	electro-transport	overall	balancing	concentration	needed	optimal
